25 research outputs found
Integrated datasets of proteomic and metabolomic biomarkers to predict its impacts on comorbidities of type 2 diabetes mellitus
© 2020 Cheema et al. Objective: The objective of the current study is to accomplish a relative exploration of the biological roles of differentially dysregulated genes (DRGs) in type 2 diabetes mellitus (T2DM). The study aimed to determine the impact of these DRGs on the biological pathways and networks that are related to the associated disorders and complications in T2DM and to predict its role as prospective biomarkers. Methods: Datasets obtained from metabolomic and proteomic profiling were used for investigation of the differential expression of the genes. A subset of DRGs was integrated into IPA software to explore its biological pathways, related diseases, and their regulation in T2DM. Upon entry into the IPA, only 94 of the DRGs were recognizable, mapped, and matched within the database. Results: The study identified networks that explore the dysregulation of several functions; cell components such as degranulation of cells; molecular transport process and metabolism of cellular proteins; and inflammatory responses. Top disorders associated with DRGs in T2DM are related to organ injuries such as renal damage, connective tissue disorders, and acute inflammatory disorders. Upstream regulator analysis predicted the role of several transcription factors of interest, such as STAT3 and HIF alpha, as well as many kinases such as JAK kinases, which affects the gene expression of the dataset in T2DM. Interleukin 6 (IL6) is the top regulator of the DRGs, followed by leptin (LEP). Monitoring the dysregulation of the coupled expression of the following biomarkers (TNF, IL6, LEP, AGT, APOE, F2, SPP1, and INS) highlights that they could be used as potential prognostic biomarkers. Conclusion: The integration of data obtained by advanced metabolomic and proteomic technologies has made it probable to advantage in understanding the role of these biomarkers in the identification of significant biological processes, pathways, and regulators that are associated with T2DM and its comorbidities
Prevalence and risk factors for diabetic neuropathy and painful diabetic neuropathy in primary and secondary health care in Qatar.
AIMS/INTRODUCTION:This study determined the prevalence and risk factors for DPN and pDPN in patients with type 2 diabetes (T2D) in primary health care (PHC) and secondary health care (SHC) in Qatar. MATERIALS AND METHODS:This is a cross-sectional multi-center study. Adults with T2D were randomly enrolled from four PHC centres and two Diabetes Centres in SHC in Qatar. Subjects underwent assessment of clinical and metabolic parameters, DPN and pDPN. RESULTS:1,386 subjects with T2D (297 from PHC and 1,089 from SHC) were recruited. The prevalence of DPN (14.8% vs 23.9%, P=0.001) and pDPN (18.1% vs 37.5%, P<0.0001) was significantly lower in PHC compared to SHC, whilst those with DPN at high risk for DFU (31.8% vs 40.0%, P=0.3) was comparable. The prevalence of undiagnosed DPN (79.5% vs 82.3%, P=0.66) was comparably high but undiagnosed pDPN (24.1% vs 71.5%, P<0.0001) was lower in PHC compared to SHC. The odds of DPN and pDPN increased with age and diabetes duration and DPN increased with poor glycemic control, hyperlipidemia and hypertension, whilst pDPN increased with obesity and reduced physical activity. CONCLUSIONS:The prevalence of DPN and pDPN in T2D is lower in PHC compared to SHC and is attributed to overall better control of risk factors and referral bias due to patients with poorly managed complications being referred to SHC. However, ~80% of patients had not been previously diagnosed with DPN in PHC and SHC. Further, we identify a number of modifiable risk factors for PDN and pDPN
Carnosine as a Protective Factor in Diabetic Nephropathy: Association With a Leucine Repeat of the Carnosinase Gene CNDP1
Role of SLMAP genetic variants in susceptibility of diabetes and diabetic retinopathy in Qatari population
Genetics, obesity, and environmental risk factors associated with type 2 diabetes
Aim To determine the association between consanguineous marriages, obesity, and environmental risk factors associated with type 2 diabetes, in the adult Qatari population
Bone density measured by dual energy X-ray absorptiometry in Qatari women
Background: Over the past 10 years, osteoporosis has emerged as a major public health problem. It is characterized by low bone mass with micro architectural deterioration of bone tissue resulting in increase bone fragility and susceptibility to fractures. Bone mineral density measurements are widely used to diagnose osteoporosis and to assess its severity. Commercial dual-energy X-rays absorptiometry (DXA) scanners used to determine bone mineral density (BMD) contains reference data for different populations
Complications of Diabetes Mellitus Among Patients Attending Outpatient Clinics in Qatar
The objective of this study was to explore the prevailing complications of diabetes mellitus and to explore some of the associated factors among Qatari patients previously diagnosed as having diabetes mellitus. A random sample of Qatari diabetic patients attending outpatient clinics (8 am to 12 pm) attached to Hamad General Hospital, between May 2001-2002 were included in the study. The total sample was 225, 74 males, and 151 females. The results revealed that retinopathy was the most prevailing complication (43.6%), followed by nephropathy (40.9%), hypertension (36.9%), neuropathy (28.9%), hyperlipidemia (26.7%), coronary heart disease (18.7%), foot ulcer (4.4%), and thyroid problems (3.6%). A significant association between development of hypertension and high body mass index (BMI) was found. Neuropathy and thyroid problems were significantly higher in females. (56.9%) of the patients were obese (BMI >30 kg/m2), and 28.9% were overweight (BMI 25-29.9). Two thirds of the patients had positive family history of the disease, and females who had diabetic fathers were significantly higher than males.qscienc
Metabolic Syndrome and its components among Qatari population
Metabolic Syndrome (MeS) is a cluster of abnormalities including
impaired glucose metabolism, central obesity, dyslipidemia and hypertension.
The MeS has not been widely studied among the Arab populations, but the data
available suggests that it is an increasingly common problem. Prevalence of
MeS and its associated components are not available in Qatar. To estimate the
prevalence of MeS and its associated components among the Qatari population
and to determine its associated risk factors. A cross-sectional study was carried out among Qatari adults aged 20 years and above. Face to face interviewing
using a structured questionnaire followed by laboratory tests were conducted.
MeS was defined using the Adult Treatment Panel III (ATP III) criteria as well
as the International Diabetes Federation criteria (IDF). The crude prevalence
rate of MeS according to ATP III criteria and IDF criteria were 26.4 and
34.0%, respectively. The age-standardised prevalence of the MeS according to
ATP III was 27.7% (95% CI 23.3–32.0%), (23.6% among men (95% CI 19.5–
27.7%) and 32.6% among women (95% CI 28.0–37.2%)) and according to IDF
criteria, the age standardised prevalence was 35.4% (95% CI 30.7–40.0%),
38.7% (95% CI 34.0–43.5%) for women and 35.8% (95% CI 31.2–40.5%) for
men. Age, Body Mass Index and HbA1c were significantly associated with
MeS after adjustment for a number relevant variables including; gender, marital
status, educational level, exercise, smoking, etc. Prevalence of the MeS in
Qatar is considerably higher than anticipated. A well-designed health education
programmes to increase the awareness of the public as well as healthcare
providers are highly recommended. The programme should focus on the risk
factors and the health consequences of MeS
Impact of the Pro12Ala polymorphism of the PPARγ2 gene on diabetes and obesity in a highly consanguineous population
Background: The peroxisome proliferator-activated receptors (PPARs) are members of the nuclear hormone receptor subfamily of transcription factors. It has been reported that they play important roles in obesity and the development of type 2 diabetes mellitus (T2DM). Materials and Methods: This case-control study was carried out among 764 Qatari patients with diabetes and 764 healthy subjects above 20 years of age at Primary Healthcare Clinics (PHCs) from January 2011 to December 2012. Face-to-face interviews were based on a questionnaire that included variables such as age, sex, sociodemographic status, body mass index (BMI) and other clinical parameters. The Pro12Ala in the PPARγ2 gene was detected on the LightCycler using two specific probes. Univariate and multivariate statistical analysis were performed. Results: The study revealed that in the diabetes group, Pro/(10.2% vs 9.4%; P = 0.606) and Ala/Ala (1.4% vs 0.9%; P = 0.343) were higher than in controls, whereas Pro/Pro (88.4% vs 89.7%;P = 0.413) was lower in diabetes patients, but no significant difference was observed among the genotype groups. In obese patients with diabetes, Pro/Pro (89% vs 89.9%;P = 0.792) and Pro/Ala (8.9% vs 10.1%;P = 0.671) were lower than in obese healthy subjects. No homozygous Ala/Ala was found in obese healthy subjects, whereas 6 Ala/Ala homozygotes were in obese diabetes group. But in diabetes group, obese patients had higher homozygous of Pro/Pro (89.3% vs 87.8%;P = 0.523) and Ala/Ala (1.8% vs 1.2%;P = 0.771) compared to non-obese patients. Conclusion: The current study did not reveal an association between the Pro12Ala polymorphism of the PPAR γ2 gene and type 2 diabetes (T2D) in Qatari′s population
Lipoprotein profile in Arabian type 2 diabetic patients. Relationship to coronary artery diseases
Aim: The aim of this study was to assess lipoprotein profile in Qatari patients with type 2 diabetes mellitus (T2DM) and to assess its relationship to coronary artery disease ( CAD). Subjects and methods: This is a prospective study conducted during a period May to October 2004 at the Hamad General Hospital, Doha, State of Qatar. Sample included Qatari nationals ( 180 with diabetes and 180 without) aged 25 to 65 years. Results: The present study revealed that consanguinity, obesity, total cholesterol, reduced HDL-cholesterol and triglyceride were more prevalent in diabetic patients. Also, there was statistically significant difference in biochemistry levels between diabetic patients with CAD and without CAD for age, gender, serum creatinine, triglycerides and BMI. The patients' LDL correlated significantly with total Cholesterol and Lp B. Total cholesterol correlated significantly with triglycerides, Lp B and Lp ( A). Conclusion: The present study showed that Lp( a) may not be an independent risk factor for CAD in patients with DM. (c) 2006 Elsevier Ireland Ltd. All rights reserved